Lipid Peroxidation During Nitric Oxide Therapy in Preterm Infants 72

AIMS: A pilot study in preterm infants to determine the effect of inhaled nitric oxide therapy (INO) on urinary malondialdehyde (MDA),a product of lipid peroxidation and a marker of oxidant/antioxidant activity.

SUBJECTS:Preterm infants < 32 weeks receiving INO therapy(part of randomised controlled study).

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD